Skip to main content
Premium Trial:

Request an Annual Quote

Millipore, Burnham Institute, Imgenex, Dendritics

Premium
Millipore and Burnham Institute To Run Stem Cell Workshops
 
Millipore this week announced the development of training workshops on human stem cell research in conjunction with the Burnham Institute for Medical Research. According to Millipore, this collaboration between a commercial entity and a research institute is the first of its kind.
 
Millipore and the Burnham Institute will hold four- or five-day workshops at least once per quarter. The workshops will be conducted by a team of Millipore, Burnham Institute, and independent stem cell specialists.
 
As sole sponsor of the workshops, Millipore will work with the Burnham Institute to develop, organize, and execute the events. The workshops will feature laboratory experiments and technical seminars. The Burnham Institute will host the workshops at its campus in La Jolla, Calif. The first workshop is tentatively scheduled for September. 
 
Interested parties will be able to register for the workshops and view syllabi and workshop leader information online beginning in August (www.millipore.com/burnham-workshops). Class size will initially be limited to nine participants per workshop. There will be a fee of $1,500 to participate.
 

 
Imgenex Will Exclusively Distribute Dendritics’ MAbs
 
Imgenex this week announced that it has signed an exclusive distribution agreement with Dendritics of Dardilly, France, to make its portfolio of monoclonal antibodies available to researchers in North America and India. 
 

Comprised of former scientists from Schering Plough’s laboratory for immunological research, Dendritics offers a collection of DC related reagents validated for flow, IHC, and functional inhibitory assays. Purified, biotin, and Alexa Fluor formats are available. 

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.